Navigation Links
Data from FREEDOM-301 Study for LEVADEX™ Orally Inhaled Migraine Drug Published in 'Headache'
Date:4/7/2011

but some last as long as three days.  On average, migraine sufferers experience 3 migraine attacks monthly, although 25 percent of them experience one or more attacks weekly.  The economic burden of migraine remains substantial despite existing treatments, with the direct and indirect costs of migraine in the United States estimated at over $20 billion annually.

About MAP Pharmaceuticals MAP Pharmaceuticals is an emerging biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX, an orally inhaled investigational therapy for the acute treatment of migraine. The Company has reported positive results from its Phase 3 trial of LEVADEX and has entered into a collaboration agreement with Allergan, Inc. to co-promote LEVADEX to neurologists and pain specialists in the U.S. MAP Pharmaceuticals also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.  Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com

Forward-Looking Statements In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the preparation and filing of a New Drug Application and the regulatory process to have the company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking stat
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
2. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
10. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... Advanced Bearing Technology with Vitamin E by celebrating a ... this month reported that, at 96 million cycles of ... Technology featuring Vitamin E grafted highly crosslinked polyethylene hip ... reduction of 95 percent, with no cracking, delamination or ...
(Date:3/26/2015)... -- Even the Score today marked this week,s 17 ... landmark approval of Viagra with the release of a ... the Agency to begin restoring gender equity in sexual ... most common sexual dysfunction. Currently, men have ... dysfunction – while women have zero biological treatment options ...
(Date:3/26/2015)... , March 26, 2015 ... and Drug Safety Software Market by Functionality (Adverse Event ... based (SAAS)), End-user (Pharma & Biotech Companies, CROs, ... MarketsandMarkets, the Pharmacovigilance and Drug Safety Software Market ... 6.5% during 2014-2019, and is expected to reach ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
... July 27, 2011 Reportlinker.com announces that ... in its catalogue: India ... Till 2016 http://www.reportlinker.com/p0575381/India-Cardiac-Catheters-and-Guidewires---Market-Trends-Till-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... This market report provides vital ...
... 26, 2011 Symmetry Medical Inc. (NYSE: SMA ... orthopaedic device industry and other medical markets, announced today that ... period ending July 2, 2011 before the market opens on ... conference call at 8:00 a.m. ET on Thursday, August 4, ...
Cached Medicine Technology:India Cardiac Catheters and Guidewires - Market Trends Till 2016 2India Cardiac Catheters and Guidewires - Market Trends Till 2016 3Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:3/27/2015)... 2015 In light of two lawsuits ... U.S. District Court, District of Massachusetts; and case number ... of Pennsylvania), the San Diego personal injury lawyers of ... announcing that they are available to investigate potential ... were prescribed Zofran while pregnant and who gave birth ...
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 UC Davis will establish a ... origins of schizophrenia: A Silvio O. Conte Center for ... such centers in the United States. , The center ... the National Institutes of Mental Health, which will allow ... that an origin of schizophrenia may be dysregulation of ...
(Date:3/26/2015)... 26, 2015 Xarelto lawsuits ( ... with the issuance of new court documents in ... According to an Order dated March 24th, the ... Xarelto injury claims in the U.S. District Court, ... to file cases directly in the proceeding. (In ...
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate the ... parents who are working to reduce sugar in their family ... public health, and we will continue to stand on the ... families,” said Dr. Jane Delgado President and CEO of the ... Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. DeLauro. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2
... the illness and depression, anxiety disorders, researchers say , ... of people with Parkinson,s disease are at increased risk ... The risk is particularly high in the brothers, sisters, ... age 75, said a team from the Mayo Clinic ...
... of Native American tribes, public health and environmental ... in,the U.S. Court of Appeals for the District ... that evade legally required cuts in,mercury pollution from ... broad coalition called for the complete reversal of ...
... Los,Angeles Jewish Home today broke ground on the first ... a decade, the newest in,California and the fastest-selling CCRC ... years after the city,s first senior housing was created ... to the number of,elderly residing in the region. Fountainview ...
... MOINES, Iowa, Dec. 6 A group of physicians ... appealing to both Democratic and,Republican candidates for President to ... highest quality hospitals, including their own., The appeal ... that was,prompted by threatened action by Senator Max Baucus, ...
... of Frutels, the Vitamin ... Gummy for Acne, ... principal of new business development consultancy BANKS., has,agreed to join Frutels, LLC ... years of executive marketing experience in apparel,cosmetics, fragrance and fashion accessories to ...
... to enhance care for Philadelphia Latinos, PHILADELPHIA, Dec. ... providing a total of $925,000 in funding through 2010,to ... of its,Charitable Medical Care Grant Program. The Grant program, ... that provide,free or low-cost health care to more than ...
Cached Medicine News:Health News:Relatives of Parkinson's Patients at Higher Psychiatric Risk 2Health News:EPA Plan to Evade Required Cuts in Mercury Pollution Challenged in Court by States, Tribes, Health and Environmental Groups 2Health News:Construction Begins on Los Angeles' First New Continuing Care Retirement Community Facility in Over a Decade 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 3Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 4Health News:Marketing Powerhouse Wendy Banks Joins Frutels' Advisory Board 2Health News:Independence Blue Cross Gives Grants to Support Health Care for the Uninsured 2
Pefakit PiCT UFH Controls...
Pefakit PiCT LMWH Controls...
Pefakit PiCT LMWH Calibrators...
Pefakit TAFI Calibrators and Controls...
Medicine Products: